Prandin 2mg

Posted: lingele Date of post: 22-Feb-2019
<b>PRANDIN</b> Dosage & Rx Info Uses, Side Effects - MPR

PRANDIN Dosage & Rx Info Uses, Side Effects - MPR

Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. It is sold by Novo Nordisk under the name of Prandin in the U. S., Gluco Norm in Canada, Surepost in Japan, Repaglinide in Egypt by EIPICO, and Novo Norm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma. Administration of both repaglinide and one or more of these drugs results in an increase in plasma concentration of repaglinide and may lead to hypoglycemia. Co-administration of repaglinide and clopidogrel (a CYP2C8 inhibitor) may lead to a significant decrease in blood glucose levels due to a drug-drug interaction. Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.

Repaglinide By mouth - National Library of Medicine.

Repaglinide By mouth - National Library of Medicine.

Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. Read the Patient Information leaflet if one is available from your pharmacist before you start using repaglinide and each time you get a refill. If you have any questions, consult your doctor or pharmacist. Take this medication by mouth within 30 minutes before each meal as directed by your doctor, usually 2-4 times daily depending on the number of meals. PRANDIN (repaglinide) is an oral blood glucose-lowering drug of the meglitinide class used in the management of type 2 diabetes mellitus (also known as non-insulin dependent diabetes mellitus or NIDDM). Repaglinide, S( ) 2-ethoxy-4(2((3-methyl-1-(2-(1-piperidinyl) phenyl)-butyl)amino)-2-oxoethyl) benzoic acid, is chemically unrelated to the oral sulfonylurea insulin secretagogues. The structural formula is as shown below: and a molecular weight of 452.6. PRANDIN tablets contain 0.5 mg, 1 mg, or 2 mg of repaglinide. In addition each tablet contains the following inactive ingredients: calcium hydrogen phosphate (anhydrous), microcrystalline cellulose, maize starch, polacrilin potassium, povidone, glycerol (85%), magnesium stearate, meglumine, and poloxamer. The 1 mg and 2 mg tablets contain iron oxides (yellow and red, respectively) as coloring agents. Repaglinide lowers blood glucose levels by stimulating the release of insulin from the pancreas.

Repaglinide oral - CardioSmart
Repaglinide oral - CardioSmart

Repaglinide is an oral diabetes medicine that helps control blood sugar levels. This medication lowers blood sugar by causing the pancreas to produce insulin. Mg tablets peach, biconvex tablets, embossed with the Novo Nordisk Apis bull symbol. 4. CONTRAINDICATIONS. PRANDIN is contraindicated in patients.

Prandin 2mg
Rating 4,8 stars - 656 reviews